Welcome to Journal of Beijing Institute of Technology
Volume 22Issue 1
.
Turn off MathJax
Article Contents
FU Yan-jie, SUN Li-quan, FAN Xin-yuan, LIU Cong, YAO Guo-wei, LUO Ai-qin. Improvement in synthesis of 3'-N-demethylazithromycin and its derivatives[J]. JOURNAL OF BEIJING INSTITUTE OF TECHNOLOGY, 2013, 22(1): 130-134.
Citation: FU Yan-jie, SUN Li-quan, FAN Xin-yuan, LIU Cong, YAO Guo-wei, LUO Ai-qin. Improvement in synthesis of 3'-N-demethylazithromycin and its derivatives[J].JOURNAL OF BEIJING INSTITUTE OF TECHNOLOGY, 2013, 22(1): 130-134.

Improvement in synthesis of 3'-N-demethylazithromycin and its derivatives

  • Received Date:2012-04-20
  • 3'- N-demethylazithromycin is an impurity in azithromycin drug. It is derived by demethylation of azithromycin, i.e., azithromycin loses a methyl group on the 3'- Nposition. In this study, bulk product was purified with chromatographic separation. It was observed that 3'- N-demethylazithromycin was also a precursor of other impurities. Simultaneously, another derivative was synthesized, i.e., 3'- N-demethyl-3'- N-formylazithromycin. Reaction conditions were optimized with the HPLC method and good-quality and high-yield derivative product was achieved. The structures of derivatives were identified by 1H-NMR and MS.
  • loading
  • [1]
    Treadway G. Azithromycin: a new 15-membered macrolide[J]. TheJournal of Antibiotics, 2001, 54: 70-76.
    [2]
    Lode H, Borner K, Koeppe P, et al. Azithromycin—review of key chemical, phannacokinetic and microbiological features[J]. Journal of Antimicrobial Chemotherapy, 1996, 37: 1-8.
    [3]
    Kiran M M, Gokul L P, Mangesh B C, et al. A process for preparing 6,9-imino ether: WO2007015265[P]. 2007-02-08.
    [4]
    Immaculada B, Victor C, Jose D, et al. Macrolide intermediates: WO0027856[P]. 2000-05-18.
    [5]
    Wilkening R R, Ratcliffe R W, Doss G A, et al. Novel transannular Beckmann rearrangement of azalide iminoethers[J].Tetreahedron, 1997, 53(50): 16923-16944.
    [6]
    Miguel B J, Rodrigo J C, Fernando L O. Synthesis of 9-deoxo-9a-aza- 9a-homoerythromycin A 11, 12-hydrogen borate and azithromycin 11,12-hydrogen borate: a new procedure to obtain azithromycin dihydrate[J]. Journal of Organic Chemistry, 1997, 62(21): 7479-7481.
    [7]
    European Directorate for the Quality of Medicines. Europeanpharmacopoeia 6.0[S]. Norwich: TSO Publishing Solution, 2007: 1238-1240.
    [8]
    The United Stated Pharmacopeia Convention. The United States pharmacopoeia, 32th edition[S]. Maryland: U.S.P. Convention, 2007: 1613.
    [9]
    Anjan C, Baban S Y, Sambhaji J J, et al. Macrolide derivatives as antibacterial agents: WO2008111020[P].2008-09-18.
    [10]
    Ashoke B, Duffy E M, Kanyo Z F, et al. Macrolide compounds and methods of making and using the same: WO2008143730[P]. 2008-11-27.
    [11]
    Albert C, Jose D, Rafael G, et al.Derivatives of azithromycin: WO2004092736[P]. 2004-10-28.
  • 加载中

Catalog

    通讯作者:陈斌, bchen63@163.com
    • 1.

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Article Metrics

    Article views (2098) PDF downloads(1887) Cited by()
    Proportional views
    Related

    /

      Return
      Return
        Baidu
        map